Assessment of blood loss and ways of its compensation in patients undergoing orthopedic oncologic surgery (analysis of 7 years’ experience)

Background. The goal of study is to estimate blood loss, allogeneic red blood cells, fresh frozen plasma requirement during and after different types of orthopedic oncologic surgery. Methods. From 2006 to 2012, 546 patients undergoing proximal femur, distal femur, total femur, proximal tibia, proximal humeral resections with endoprosthetic reconstruction were enrolled in the retrospective study. Operative blood loss, transfused allogeneic red blood cells, allogeneic fresh frozen plasma was calculated. Results. Median intra / post-operative blood loss by total hip replacement was 800/475, total knee - 600/840, total femur - 1600/1010, hemischoulder arthroplasty - 600/390 ml. Percent of patients received allogeneic red blood cell / fresh frozen plasma was 47/38%, 34/26%, 93/86% and 22/12% accordingly. Massive blood loss during total hip replacement was in 10%, total knee - 2%, total femur - 35%, hemischoulder arthroplasty - 5% of all cases. Conclusions. It was required to treat blood loss per one operated patient (allogeneic red blood cells / fresh frozen plasma) during total hip replacement - 308/312, total knee - 197/151, total femur - 773/700, hemischoulder arthroplasty - 136/92 ml.

операционная кровопотеря, эндопротезирование тазобедренного, коленного, плечевого суставов, тотальное эндопротезирование бедренной кости, operative blood loss, proximal femur, distal femur, total femur, proximal tibia, proximal humeral resections, endoprosthetic reconstruction